Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12548 | 897 | 35.3 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
3464 | 2 | FLAVIN CONTAINING MONOOXYGENASE//FMO3//TRIMETHYLAMINURIA | 1499 |
12548 | 1 | FLAVIN CONTAINING MONOOXYGENASE//FMO3//TRIMETHYLAMINURIA | 897 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FLAVIN CONTAINING MONOOXYGENASE | authKW | 2633224 | 12% | 72% | 107 |
2 | FMO3 | authKW | 1192103 | 5% | 85% | 41 |
3 | TRIMETHYLAMINURIA | authKW | 1183995 | 4% | 87% | 40 |
4 | TRIMETHYLAMINE N OXIDE | authKW | 708942 | 6% | 39% | 54 |
5 | FISH ODOUR SYNDROME | authKW | 442522 | 1% | 100% | 13 |
6 | FISH ODOR SYNDROME | authKW | 408482 | 1% | 100% | 12 |
7 | FLAVIN CONTAINING MONOOXYGENASE 3 | authKW | 403101 | 2% | 79% | 15 |
8 | TRIMETHYLAMINE | authKW | 277913 | 5% | 17% | 49 |
9 | FMO | authKW | 219563 | 3% | 24% | 27 |
10 | UNITE TOXICOL METAB COMPA XENOBIOT | address | 175062 | 1% | 86% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3476 | 37% | 0% | 333 |
2 | Toxicology | 2872 | 17% | 0% | 156 |
3 | Biochemistry & Molecular Biology | 541 | 24% | 0% | 213 |
4 | Biophysics | 192 | 6% | 0% | 57 |
5 | Chemistry, Analytical | 104 | 6% | 0% | 55 |
6 | Biochemical Research Methods | 93 | 4% | 0% | 39 |
7 | Genetics & Heredity | 84 | 5% | 0% | 49 |
8 | Endocrinology & Metabolism | 80 | 5% | 0% | 44 |
9 | Chemistry, Medicinal | 73 | 3% | 0% | 31 |
10 | Medicine, Research & Experimental | 68 | 4% | 0% | 40 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNITE TOXICOL METAB COMPA XENOBIOT | 175062 | 1% | 86% | 6 |
2 | ST MARYS HOSP MED PHARMACOL TOXICOL | 68080 | 0% | 100% | 2 |
3 | QUEEN SIRIKIT HEART NORTHEAST | 38291 | 0% | 38% | 3 |
4 | ANIM GENOM BIOTECHNOL FOOD | 34040 | 0% | 100% | 1 |
5 | BIOL SYST PROC ENGN | 34040 | 0% | 100% | 1 |
6 | BIOLLL PFLANZENPHYSIOL | 34040 | 0% | 100% | 1 |
7 | BIOMAT BIOENEGN | 34040 | 0% | 100% | 1 |
8 | BIYOKIMYA ANABILIM DALI BIYOL BOLUMU | 34040 | 0% | 100% | 1 |
9 | CARDIOLINSERMU938 | 34040 | 0% | 100% | 1 |
10 | CARDIOVASC SCI NIHR LEICESTER | 34040 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 26866 | 9% | 1% | 77 |
2 | PHARMACOGENETICS | 10377 | 2% | 2% | 17 |
3 | XENOBIOTICA | 6858 | 3% | 1% | 28 |
4 | BIOCHEMICAL PHARMACOLOGY | 4017 | 5% | 0% | 47 |
5 | CHEMICAL RESEARCH IN TOXICOLOGY | 3738 | 3% | 0% | 24 |
6 | DRUG METABOLISM AND PHARMACOKINETICS | 2300 | 1% | 1% | 7 |
7 | MOLECULAR PHARMACOLOGY | 1975 | 3% | 0% | 24 |
8 | DRUG METABOLISM REVIEWS | 1664 | 1% | 1% | 7 |
9 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 1315 | 3% | 0% | 26 |
10 | JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY | 876 | 1% | 1% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FLAVIN CONTAINING MONOOXYGENASE | 2633224 | 12% | 72% | 107 | Search FLAVIN+CONTAINING+MONOOXYGENASE | Search FLAVIN+CONTAINING+MONOOXYGENASE |
2 | FMO3 | 1192103 | 5% | 85% | 41 | Search FMO3 | Search FMO3 |
3 | TRIMETHYLAMINURIA | 1183995 | 4% | 87% | 40 | Search TRIMETHYLAMINURIA | Search TRIMETHYLAMINURIA |
4 | TRIMETHYLAMINE N OXIDE | 708942 | 6% | 39% | 54 | Search TRIMETHYLAMINE+N+OXIDE | Search TRIMETHYLAMINE+N+OXIDE |
5 | FISH ODOUR SYNDROME | 442522 | 1% | 100% | 13 | Search FISH+ODOUR+SYNDROME | Search FISH+ODOUR+SYNDROME |
6 | FISH ODOR SYNDROME | 408482 | 1% | 100% | 12 | Search FISH+ODOR+SYNDROME | Search FISH+ODOR+SYNDROME |
7 | FLAVIN CONTAINING MONOOXYGENASE 3 | 403101 | 2% | 79% | 15 | Search FLAVIN+CONTAINING+MONOOXYGENASE+3 | Search FLAVIN+CONTAINING+MONOOXYGENASE+3 |
8 | TRIMETHYLAMINE | 277913 | 5% | 17% | 49 | Search TRIMETHYLAMINE | Search TRIMETHYLAMINE |
9 | FMO | 219563 | 3% | 24% | 27 | Search FMO | Search FMO |
10 | FMO3 GENE | 170201 | 1% | 100% | 5 | Search FMO3+GENE | Search FMO3+GENE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KRUEGER, SK , WILLIAMS, DE , (2005) MAMMALIAN FLAVIN-CONTAINING MONOOXYGENASES: STRUCTURE/FUNCTION, GENETIC POLYMORPHISMS AND ROLE IN DRUG METABOLISM.PHARMACOLOGY & THERAPEUTICS. VOL. 106. ISSUE 3. P. 357 -387 | 188 | 70% | 202 |
2 | CASHMAN, JR , ZHANG, J , (2006) HUMAN FLAVIN-CONTAINING MONOOXYGENASES.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 46. ISSUE . P. 65 -100 | 102 | 78% | 115 |
3 | PHILLIPS, IR , SHEPHARD, EA , (2017) DRUG METABOLISM BY FLAVIN-CONTAINING MONOOXYGENASES OF HUMAN AND MOUSE.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 13. ISSUE 2. P. 167 -181 | 101 | 70% | 0 |
4 | KOUKOURITAKI, SB , HINES, RN , (2005) FLAVIN-CONTAINING MONOOXYGENASE GENETIC POLYMORPHISM: IMPACT ON CHEMICAL METABOLISM AND DRUG DEVELOPMENT.PHARMACOGENOMICS. VOL. 6. ISSUE 8. P. 807-822 | 69 | 93% | 36 |
5 | PHILLIPS, IR , SHEPHARD, EA , (2008) FLAVIN-CONTAINING MONOOXYGENASES: MUTATIONS, DISEASE AND DRUG RESPONSE.TRENDS IN PHARMACOLOGICAL SCIENCES. VOL. 29. ISSUE 6. P. 294-301 | 61 | 91% | 54 |
6 | CASHMAN, JR , ZHANG, J , (2002) INTERINDIVIDUAL DIFFERENCES OF HUMAN FLAVIN-CONTAINING MONOOXYGENASE 3: GENETIC POLYMORPHISMS AND FUNCTIONAL VARIATION.DRUG METABOLISM AND DISPOSITION. VOL. 30. ISSUE 10. P. 1043 -1052 | 71 | 85% | 57 |
7 | CASHMAN, JR , (1995) STRUCTURAL AND CATALYTIC PROPERTIES OF THE MAMMALIAN FLAVIN-CONTAINING MONOOXYGENASE.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 8. ISSUE 2. P. 165-181 | 98 | 73% | 105 |
8 | MOTIKA, MS , ZHANG, J , CASHMAN, JR , (2007) FLAVIN-CONTAINING MONOOXYGENASE 3 AND HUMAN DISEASE.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 3. ISSUE 6. P. 831-845 | 63 | 85% | 13 |
9 | FENNEMA, D , PHILLIPS, IR , SHEPHARD, EA , (2016) TRIMETHYLAMINE AND TRIMETHYLAMINE N-OXIDE, A FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3)-MEDIATED HOST-MICROBIOME METABOLIC AXIS IMPLICATED IN HEALTH AND DISEASE.DRUG METABOLISM AND DISPOSITION. VOL. 44. ISSUE 11. P. 1839 -1850 | 74 | 54% | 1 |
10 | BAIN, MA , FORNASINI, G , EVANS, AM , (2005) TRIMETHYLAMINE: METABOLIC, PHARMACOKINETIC AND SAFETY ASPECTS.CURRENT DRUG METABOLISM. VOL. 6. ISSUE 3. P. 227-240 | 79 | 62% | 34 |
Classes with closest relation at Level 1 |